Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility

"Your firm failed to clean, maintain, and, as appropriate for the nature of the drug, sanitise and/or sterilise equipment and utensils at appropriate intervals to prevent malfunctions or contamination that would alter the safety, identity, strength, quality, or purity of the drug product beyond the official or other established requirements," the USFDA said.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/IT1PXKa
via IFTTT